GLP-1s
PulseAugur coverage of GLP-1s — every cluster mentioning GLP-1s across labs, papers, and developer communities, ranked by signal.
4 day(s) with sentiment data
-
RonanRx launches personalized peptide and GLP-1 platform
RonanRx, a Y Combinator S26 startup, is developing a vertically integrated pharmaceutical company focused on personalized peptides and GLP-1 medications. The company aims to streamline the entire process from prescripti…
-
Bank of America maintains GLP-1 coverage amid employer trend reversal
Bank of America is distinguishing itself by continuing to offer comprehensive employer-sponsored coverage for GLP-1 medications used to treat obesity. This stance contrasts with a broader industry trend where many compa…
-
Medicaid weight loss drug access model sees minimal state participation
A voluntary Medicaid demonstration project aimed at expanding access to weight loss drugs, known as the BALANCE model, has garnered very little interest from states, with Indiana being the only confirmed participant. Th…
-
AI and modern conveniences blamed for 'joyless decadence'
Hosts Kai Wright and Carter Sherman explore the paradox of modern life, where technological advancements and conveniences paradoxically lead to feelings of emptiness and a lack of joy. They discuss with academics Michèl…
-
Medical startup sells $345 nuclear disaster kit, experts call it overpriced
A telehealth startup named Amble Health is selling a $345 "Oh Sh*t Kit" containing prescription medications like iodine tablets and anti-nausea drugs, marketed as a preparedness measure for nuclear disasters. While the …
-
Telehealth network scammed customers out of $5M for GLP-1s
Customers have reported being scammed by a telehealth network that sells compounded GLP-1 medications. This network was previously ordered to pay $5 million to clients as part of a settlement with the US government. The…
-
Weight loss drug coverage uncertain despite insurer formulary listings
Despite Eli Lilly's announcement that its obesity medications will be listed on the formularies of major pharmacy benefit managers, actual coverage remains uncertain. Many health insurers and plan sponsors are reluctant…
-
SCMP Lifestyle: Consort Wan's tale and GLP-1s highlighted
This cluster focuses on lifestyle highlights from SCMP's recent reporting, including a historical piece about Consort Wan and her relationship with Emperor Chenghua. It also touches upon the benefits and potential downs…